CardiaCare Announces Licensing and Distribution Agreement to Commercialize its Digital Neuromodulation Wearable for Non-invasive Atrial Fibrillation Treatment
CardiacSense receives FDA Clearance for Medical Watch
CardiacSense was granted FDA clearance for Beat-by-Beat Heart Rate, and Oxygen Saturation (SpO2)
Proprietary sensors enable highly accurate and reliable measurement of vital signs (99% sensitivity and specificity for beat-by-beat heart rate when comparted to Holter Monitor)
CardiacSense plans to file additional indications during 2023 and has already gathered much of the clinical data required to support these submissions
Field Medical and CardioNXT Collaborate to Deliver Novel Integration of Focal Pulsed Field Ablation and 3D Mapping & Navigation for Treatment of Cardiac Arrhythmias